Can SGLT2i use decrease the risk of atrial fibrillation in patients with heart failure with reduced ejection fraction: a retrospective cohort study

被引：0
|
作者：
Alejandro, J. [1 ]
Beloy, F. [2 ]
Khachatryan, A. [1 ]
Cinar, T. [1 ]
机构：
[1] Univ Maryland, Midtown Campus, Baltimore, MD USA
[2] Ateneo Sch Med & Publ Hlth, Pasig, Philippines
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Factors associated with SGLT2i adherence in patients with heart failure with reduced ejection fraction
    Mace, H. P.
    Coleman, C.
    Bloodworth, C.
    Wilkins, R.
    Hood, C.
    Spruiell, C.
    Hamid, A.
    Hall, Me
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369
  • [2] SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
    Sanchez Gonzalez, V. Virtudes
    Flano-Lombardo, R.
    Esteve-Ruiz, I.
    Cortez, G.
    Aranda-Dios, A.
    Duran-Torralba, C.
    Rangel-Sousa, D.
    Sobrino-Marquez, J. M.
    Grande-Trillo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 72 - 73
  • [3] Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States
    Pierce, J. B.
    Vaduganathan, M.
    Fonarow, G. C.
    Ikeaba, U.
    Chiswell, K.
    Huang, J.
    Linganathan, K.
    Mcdermott, J.
    Greene, S. J. Stephen
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 66 - 67
  • [4] ECHOCARDIOGRAPHIC FINDING BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION IN TREATMENT WITH ARNI AND SGLT2I
    Ceci, Vincenzo
    Mazzeo, Pietro
    Ferrara, Salvatore
    Nardella, Luigi
    Tricarico, Lucia
    Alfieri, Simona
    Croella, Francesca
    Amatruda, Marco
    Granatiero, Michele
    D'alessandro, Damiano
    Di Nunno, Nicola
    Pugliese, Rosanna
    Noviello, Giulia
    Correale, Michele
    Stabile, Egenio
    Stabile, Eugenio
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [5] CLINICAL CHARACTERISTICS OF PATIENTS AFFECTED BY HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AND UNDERGOING SGLT2I THERAPY
    Alcidi, G.
    Pugliese, R.
    Ioannoni, S.
    Romano, M.
    Granatiero, M.
    Diomede, D.
    Benvenuto, M.
    Correale, M.
    Brunetti, N.
    Gronda, E.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [6] Risk of genitourinary infection similar among SGLT2i in patients with heart failure and preserved ejection fraction
    Reactions Weekly, 2024, 2011 (1) : 10 - 10
  • [7] SGLT2i in heart failure: can their benefits be expanded across the entire spectrum of ejection fraction?
    Requena-Ibanez, Juan Antonio
    Santos-Gallego, Carlos G.
    Badimon, Juan Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (10): : 833 - 841
  • [8] Elderly patients with HF with reduced ejection fraction and renal failure: are SGLT2i a good option?
    Balaguer, Jorge
    Garcia, Marcelino Cortes
    Lopez, Carlos Rodriguez
    Otero, Jose Maria Romero
    Chapel, Jose Antonio Esteban
    Roca, Luis Nieto
    Urquia, Mikel Taibo
    Lazaro, Ana Maria Pello
    Tunon, Jose
    CIRCULATION, 2024, 150
  • [9] Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
    Verma, Atul
    Kalman, Jonathan M.
    Callans, David J.
    CIRCULATION, 2017, 135 (16) : 1547 - 1563
  • [10] SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this
    Soh, B. W. T.
    Balfe, C.
    O'Brien, K.
    Glasgow, J.
    Forkin, A.
    Sim, W. H.
    Muradagha, H.
    Abbas, S.
    Arnous, S.
    Kiernan, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 952 - 952
12345